- Home
- ARGX vs DXCM Comparison
ARGX vs DXCM Comparison
Compare ARGX & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- DXCM
- Stock Information
- Founded
- ARGX 2008
- DXCM 1999
- Country
- ARGX Netherlands
- DXCM United States
- Employees
- ARGX N/A
- DXCM N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- DXCM Medical/Dental Instruments
- Sector
- ARGX Health Care
- DXCM Health Care
- Exchange
- ARGX Nasdaq
- DXCM Nasdaq
- Market Cap
- ARGX 40.4B
- DXCM 32.7B
- IPO Year
- ARGX 2017
- DXCM 2005
- Fundamental
- Price
- ARGX $549.65
- DXCM $84.67
- Analyst Decision
- ARGX Strong Buy
- DXCM Strong Buy
- Analyst Count
- ARGX 20
- DXCM 18
- Target Price
- ARGX $698.22
- DXCM $98.11
- AVG Volume (30 Days)
- ARGX 423.4K
- DXCM 4.5M
- Earning Date
- ARGX 05-08-2025
- DXCM 05-01-2025
- Dividend Yield
- ARGX N/A
- DXCM N/A
- EPS Growth
- ARGX N/A
- DXCM N/A
- EPS
- ARGX 15.94
- DXCM 1.33
- Revenue
- ARGX $2,643,062,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- ARGX $60.97
- DXCM $16.49
- Revenue Next Year
- ARGX $31.50
- DXCM $15.45
- P/E Ratio
- ARGX $32.07
- DXCM $63.58
- Revenue Growth
- ARGX 82.13
- DXCM 9.11
- 52 Week Low
- ARGX $352.77
- DXCM $57.52
- 52 Week High
- ARGX $678.21
- DXCM $132.26
- Technical
- Relative Strength Index (RSI)
- ARGX 36.21
- DXCM 70.90
- Support Level
- ARGX $529.11
- DXCM $78.55
- Resistance Level
- ARGX $658.93
- DXCM $85.74
- Average True Range (ATR)
- ARGX 17.55
- DXCM 2.68
- MACD
- ARGX -6.04
- DXCM 1.92
- Stochastic Oscillator
- ARGX 15.82
- DXCM 94.71
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.